Skip to main content
editorial
. 2024 Apr 28;30(16):2184–2190. doi: 10.3748/wjg.v30.i16.2184

Table 1.

Roles of microRNAs in patients with inflammatory bowel disease

What is already known about miRNAs in IBD?
What can we expect from miRNAs in IBD?
Ref.
Regulate cellular processes and homeostasis Discover new functions in the pathophysiology of IBD [8-11]
Differentially expressed between patients with IBD and healthy controls Can be used as diagnostic markers for IBD [5,6,16-19]
Differentially expressed between UC and CD Can be used to differentiate UC from CD [6]
Differentially expressed with respect to disease activity Can be used as biomarkers of inflammatory activity [16,17,19,32]
Regulated in response to drug exposure Can be used as markers of drug responses [20]
Regulate the expression of inflammatory cytokines Potential therapeutic targets in IBD [21,22,23]
Act on the intestinal barrier Potential therapeutic targets in IBD [25,26]
Modulate the intestinal microbiota Potential therapeutic targets in IBD [27-29]

CD: Crohn’s disease; IBD: Inflammatory bowel disease; miRNA: microRNA; UC: Ulcerative colitis.